1. Novel Psychoactive Substances & Emerging Trends Michael Lawrence – NPS Development Lead 2. NPS Development Lead To co-ordinate an education and treatment response…

1. )سَنُرِيهِمْ آيَاتِنَا فِي الآفَاقِ وَفِي أَنفُسِهِمْ حَتَّىيَتَبَيَّنَ لَهُمْ أَنَّهُ الْحَقُّ…

1. David W. Salzman Yale School of Medicine Department of Therapeutic Radiology Fallopian Mucosa NSCLC Papillary Serous Ovarian Tumor DicermAb(13D6) miRNA-Target Site SNPs…

1.  Lessons  Learned:  Reali.es  of  Building  Cancer  Models-­‐Sharing  ,  Rewards  and  Affordability            Stephen  Friend  MD  PhD    …

1. WLSA CONVERGENCE SUMMIT #CSUMMIT14 Convergence Summit 2014 Mark D Wiederhold, MD PhD FACP The Virtual Reality Medical Center 2. WLSA CONVERGENCE SUMMIT #CSUMMIT14 The…

1. Sex differences confirmed in schizophrenia by means of a quantitative %PPI cocaine model and implications for treatment Samantha Lee, Bronx High School of Science 2. Abstract…

Slide 1Tony Traboulsee, MD (Neurology) University of British Columbia CMSC June 5th, 2004 Toronto, Ontario Defining suboptimal response to MS treatment: MRI outcome Slide…

Slide 1 Slide 2 Optimizing Neurotherapy and Emerging Paradigm for Alzheimers Disease The Current Foundation Role of Cholinergic Stimulation of Alzheimers DiseaseFocus on…

Slide 1Progress Against Lung Cancer Slide 2 1970–1979 Slide 3 Progress Against Lung Cancer 1970–1979 Mid-1970s: Chemotherapy combinations prove effective in small cell…

Slide 1Microbial Metagenomics Drives a New Cyberinfrastructure Invited Talk School of Biological Sciences University of California, Irvine March 3, 2006 Dr. Larry Smarr Director,…